AAREYDRUGS Share Price Target 2035
CAGR-based price projection for Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS) targeting 2035, derived from official NSE exchange closing prices.
Current Market Snapshot
Year-by-Year Price Projection
| Year | Bear Case | Base Case | Bull Case |
|---|---|---|---|
| 2027 | Rs 126 | Rs 158 | Rs 282 |
| 2028 | Rs 152 | Rs 241 | Rs 765 |
| 2029 | Rs 184 | Rs 367 | Rs 2,075 |
| 2030 | Rs 222 | Rs 558 | Rs 5,630 |
| 2031 | Rs 268 | Rs 850 | Rs 15,275 |
| 2032 | Rs 324 | Rs 1,293 | Rs 41,449 |
| 2033 | Rs 392 | Rs 1,969 | Rs 112,468 |
| 2034 | Rs 474 | Rs 2,998 | Rs 305,174 |
| 2035 | Rs 573 | Rs 4,565 | Rs 828,067 |
Frequently Asked Questions
What is the AAREYDRUGS share price target for 2035?
Based on historical growth analysis, the AAREYDRUGS share price target for 2035 ranges from Rs 573 (conservative) to Rs 4,565 (base case) to Rs 828,067 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.
What is the current share price of AAREYDRUGS?
The current market price of AAREYDRUGS (Aarey Drugs & Pharmaceuticals Limited) is Rs 103.85. The 52-week high is Rs 103.85 and 52-week low is Rs 68.21.
Is AAREYDRUGS a good stock to buy for the long term?
Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.
What methodology does BrokerLens use for AAREYDRUGS price targets?
BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 20.9% CAGR), Base (52.3% CAGR), and Bull (optimistic at 171.3% CAGR). These are statistical projections, not guaranteed forecasts.